Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Total Debt (2016)

Gyre Therapeutics has reported Total Debt over the past 7 years, most recently at $28000.0 for Q3 2016.

  • Quarterly Total Debt fell 95.86% to $28000.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $28000.0 through Sep 2016, down 95.86% year-over-year, with the annual reading at $1.2 million for FY2015, N/A changed from the prior year.
  • Total Debt was $28000.0 for Q3 2016 at Gyre Therapeutics, down from $130000.0 in the prior quarter.
  • Over five years, Total Debt peaked at $2.7 million in Q1 2012 and troughed at $28000.0 in Q3 2016.
  • The 5-year median for Total Debt is $1.1 million (2013), against an average of $1.2 million.
  • Year-over-year, Total Debt skyrocketed 41.42% in 2015 and then crashed 95.86% in 2016.
  • A 5-year view of Total Debt shows it stood at $2.0 million in 2012, then crashed by 42.83% to $1.1 million in 2013, then tumbled by 57.92% to $478000.0 in 2014, then soared by 141.84% to $1.2 million in 2015, then crashed by 97.58% to $28000.0 in 2016.
  • Per Business Quant, the three most recent readings for GYRE's Total Debt are $28000.0 (Q3 2016), $130000.0 (Q2 2016), and $196000.0 (Q1 2016).